Avalo Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.

About AVTX

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. 

CEO
Garry Arthur Neil
CEOGarry Arthur Neil
Employees
23
Employees23
Headquarters
Wayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded
2011
Founded2011
Employees
23
Employees23

AVTX Key Statistics

Market cap
68.65M
Market cap68.65M
Price-Earnings ratio
-0.26
Price-Earnings ratio-0.26
Dividend yield
—
Dividend yield—
Average volume
66.37K
Average volume66.37K
High today
$6.50
High today$6.50
Low today
$5.26
Low today$5.26
Open price
$5.60
Open price$5.60
Volume
800.93K
Volume800.93K
52 Week high
$16.00
52 Week high$16.00
52 Week low
$3.39
52 Week low$3.39

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AVTX. This list is generated using Robinhood data, and it’s not a recommendation.
Mullen Automotive
SNDL
Tilray Brands
AMC Entertainment
Plug Power
Cenntro Inc.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.